IP Verse

Nektar Therapeutics competitive analysis

Latest publications and patents of Nektar Therapeutics New

Explore the latest publications and patents granted to Nektar Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Nektar Therapeutics

EP3134123
Feb 17, 2021Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 AntibodyRevoked
EP2453962
Mar 14, 2018Negatively Biased Sealed Nebulizers Systems And MethodsRevoked
EP3094331
Dec 27, 2017Combination-Based Treatment MethodRevoked
EP7905230
Mar 15, 2011Metered Dose Inhaler With Lockout -
EP2006018840
Jan 26, 2006Aerosolizable Formulation Comprising Nicotine -
EP2006004646
Jan 12, 2006Aerosol Formulation Comprising Nicotine Salt -
EP2004091705
Oct 28, 2004Aerosolization Apparatus With Air Inlet Shield -

Latest patents of Nektar Therapeutics opposed by its competitors

Explore Nektar Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3134123
Feb 17, 2021Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody1
EP2453962
Mar 14, 2018Negatively Biased Sealed Nebulizers Systems And Methods1
EP3094331
Dec 27, 2017Combination-Based Treatment Method1

Latest PTAB cases involving Nektar Therapeutics

Discover the latest PTAB cases involving Nektar Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Nektar Therapeutics

IPR2019-01398Jul 25, 2019NOFNEKTAR THERAPEUTICSFinal Written Decision
IPR2019-01397Jul 25, 2019NOFNEKTAR THERAPEUTICSFinal Written Decision
IPR2019-01396Jul 25, 2019NOFNEKTAR THERAPEUTICSInstitution Denied
IPR2019-01395Jul 25, 2019NOFNEKTAR THERAPEUTICSInstitution Denied
IPR2019-01394Jul 25, 2019NOFNEKTAR THERAPEUTICSFinal Written Decision
IPR2019-01392Jul 25, 2019NOFNEKTAR THERAPEUTICSInstitution Denied
IPR2016-01384Jul 8, 2016NOVO NORDISKNEKTAR THERAPEUTICSTerminated-Settled
IPR2016-00049Oct 15, 2015NEPTUNE GENERICSNEKTAR THERAPEUTICSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Nektar Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NEKTAR THERAPEUTICS - 3 - 8Non-Active
GREINER6 - - - Highly Aggressive
IPSEN BIOPHARM110 - 1Defensive
NOF - - 6 - Highly Aggressive